Cartilla Therapeutics is a startup based in Switzerland, most recent round Seed.
Based in Switzerland, Cartilla Therapeutics is a startup. Its most recent tracked round is Seed.
Developing therapeutics to prevent post‑traumatic osteoarthritis (PTOA), focusing on interventions to block the pathological processes that follow joint injury. Listed by Forty51 Ventures as a Basel‑based portfolio company in 2025.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.